A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain

Pain ◽

10.1097/j.pain.0000000000000263 ◽

2015 ◽

Vol 156 (10) ◽

pp. 2013-2020 ◽

Author(s):

Dan Ziegler ◽

W. Rachel Duan ◽

Guohua An ◽

James W. Thomas ◽

Wolfram Nothaft

Keyword(s):

Neuropathic Pain ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Controlled Study ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo

Download Full-text

Short- and long-term treatment of stable effort angina with nicardipine, a new calcium channel blocker: a double-blind, placebo- controlled, randomised, repeated cross-over study.

British Journal of Clinical Pharmacology ◽

10.1111/j.1365-2125.1985.tb05164.x ◽

1985 ◽

Vol 20 (S1) ◽

pp. 195S-205S ◽

Author(s):

M. Gheorghiade ◽

C. St Clair ◽

J. St Clair ◽

D. Freedman ◽

G. Schwemer

Keyword(s):

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Term Treatment ◽

Effort Angina ◽

Double Blind ◽

Double Blind Placebo ◽

Long Term Treatment ◽

Short And Long Term

Download Full-text

A Randomized, Prospective, Double-Blind, Placebo-Controlled Trial of the Effect of a Calcium Channel Blocker Ointment on Pain After Hemorrhoidectomy

Diseases of the Colon & Rectum ◽

10.1007/s10350-005-0135-4 ◽

2005 ◽

Vol 48 (10) ◽

pp. 1913-1916 ◽

Author(s):

Ralph Silverman ◽

Phillip J. Bendick ◽

Harry J. Wasvary

Keyword(s):

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

On the cerebro-protective effects of caroverine, a calcium-channel blocker and antiglutamatergic drug: double-blind, placebo-controlled, EEG mapping and psychometric studies under hypoxia

British Journal of Clinical Pharmacology ◽

10.1111/j.1365-2125.1996.tb00165.x ◽

1996 ◽

Vol 41 (2) ◽

pp. 89-99 ◽

Author(s):

B. SALETU ◽

J. GRÜNBERGER ◽

P. ANDERER ◽

L. LINZMAYER ◽

P. KÖNIG

Keyword(s):

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Protective Effects ◽

Eeg Mapping ◽

Double Blind ◽

Double Blind Placebo ◽

Psychometric Studies

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the T-Type Calcium Channel Blocker ABT-639 in an Intradermal Capsaicin Experimental Pain Model in Healthy Adults

Pain Medicine ◽

10.1093/pm/pnv068 ◽

2015 ◽

pp. pnv068 ◽

Author(s):

Mark Wallace ◽

Rachel Duan ◽

Wei Liu ◽

Charles Locke ◽

Wolfram Nothaft

Keyword(s):

Calcium Channel ◽

Crossover Study ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Experimental Pain ◽

Healthy Adults ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the β-blocker metoprolol in severe dilated cardiomyopathy — A prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment

International Journal of Cardiology ◽

10.1016/j.ijcard.2008.02.022 ◽

2009 ◽

Vol 132 (2) ◽

pp. 248-256

Author(s):

Martin Braun ◽

Frank Edelmann ◽

Markus Knapp ◽

Steffen Schön ◽

Carsten Schwencke ◽

...

Keyword(s):

Dilated Cardiomyopathy ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Controlled Study ◽

Hemodynamic Effects ◽

Double Blind ◽

Hemodynamic Assessment ◽

Download Full-text

Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial

European Journal of Pain ◽

10.1002/ejp.1221 ◽

2018 ◽

Vol 22 (7) ◽

pp. 1321-1330 ◽

Author(s):

N. Kerckhove ◽

B. Pereira ◽

S. Soriot-Thomas ◽

H. Alchaar ◽

R. Deleens ◽

...

Keyword(s):

Neuropathic Pain ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

Controlled Trial ◽

Proof Of Concept ◽

Efficacy And Safety ◽

Download Full-text

Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study

Pain ◽

10.1016/s0304-3959(03)00317-8 ◽

2003 ◽

Vol 106 (1) ◽

pp. 151-158 ◽

Author(s):

Torsten Meier ◽

Gunnar Wasner ◽

Markus Faust ◽

Thierry Kuntzer ◽

François Ochsner ◽

...

Keyword(s):

Neuropathic Pain ◽

Controlled Study ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo ◽

Pain Syndromes ◽

Lidocaine Patch

Download Full-text

Long-term antianginal and antiischemic effects of mibefradil, the novel T-type calcium channel blocker: A multicenter, double-blind, placebo-controlled, randomized comparison with sustained-release diltiazem

American Heart Journal ◽

10.1016/s0002-8703(97)70128-5 ◽

1997 ◽

Vol 134 (2) ◽

pp. 220-228 ◽

Author(s):

Graham J. Davies ◽

Isaac Kobrin ◽

Abraham Caspi ◽

Leonardo H. Reisin ◽

Denilson Campos de Albuquerque ◽

...

Keyword(s):

Sustained Release ◽

Calcium Channel ◽

Calcium Channel Blocker ◽

Channel Blocker ◽

The Novel ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy of Pregabalin for Peripheral Neuropathic Pain: Results of an 8-Week, Flexible-Dose, Double-Blind, Placebo-Controlled Study Conducted in China

Clinical Therapeutics ◽

10.1016/j.clinthera.2011.02.007 ◽

2011 ◽

Vol 33 (2) ◽

pp. 159-166 ◽

Author(s):

Yuzhou Guan ◽

Xinsheng Ding ◽

Yan Cheng ◽

Dongsheng Fan ◽

Lan Tan ◽

...

Keyword(s):

Neuropathic Pain ◽

Controlled Study ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo ◽

Download Full-text

Faculty Opinions recommendation of Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1104054.560029 ◽

2008 ◽

Author(s):

Stephen Tyrer

Keyword(s):

Neuropathic Pain ◽

Evidence Based ◽

Double Blind ◽

Peripheral Neuropathic Pain ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Parallel Group ◽

Download Full-text